Malignant Pediatric Pelvic Tumors: A Retrospective Study
Malignant Pediatric Pelvi-abdominal Tumors: A Retrospective Study
1 other identifier
observational
90
1 country
1
Brief Summary
The aim of the study is to retrospectively review data about malignancies that arise primarily in the pelvis and/or in the pelvic organs, in pediatric cancer patients \& categorize the spectrum of these malignancies according to experience at South Egypt Cancer Institute which is the largest referral site in Upper Egypt.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2016
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 21, 2015
CompletedFirst Posted
Study publicly available on registry
September 23, 2015
CompletedStudy Start
First participant enrolled
January 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2023
CompletedJuly 24, 2023
July 1, 2023
7.8 years
September 21, 2015
July 21, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Overall survival (OS)
Time from the date of initiation of treatment until death from any cause.
Participants will be retrospectively followed forward in time from the date of initiation of treatment till the primary completion date of the study, an expected average of 5 years
Event Free Survival (EFS)
Time from the date of initiation of treatment until disease progression, or death for any reason.
Participants will be retrospectively followed forward in time from the date of initiation of treatment till the primary completion date of the study, an expected average of 5 years
Eligibility Criteria
A hospital-based study, involving Pediatric cancer patients, those diagnosed with malignant tumors of the pelvis, or arising from the pelvic organs, in the period from 2001 January till 2015 December, and received treatment at the pediatric oncology department, their medical reports will be retrospectively reviewed for data collection.
You may qualify if:
- Patients whose age less than 19 years.
- Patients diagnosed with a primary malignant tumor in the pelvis and/or arising from the pelvic organs.
You may not qualify if:
- Patients whose age more than 18 years.
- Patients diagnosed with a malignant disease primarily arising from the bone marrow.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Assiut University
Asyut, 71515, Egypt
Related Publications (2)
Groff DB. Pelvic neoplasms in children. J Surg Oncol. 2001 May;77(1):65-71. doi: 10.1002/jso.1068.
PMID: 11344486BACKGROUNDSkandalakis, J. E. and S. W. Gray (1994). Embryology for surgeons: the embryological basis for the treatment of congenital anomalies, Williams & Wilkins.
BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Lecturer, Pediatric Oncology Department
Study Record Dates
First Submitted
September 21, 2015
First Posted
September 23, 2015
Study Start
January 1, 2016
Primary Completion
November 1, 2023
Study Completion
December 1, 2023
Last Updated
July 24, 2023
Record last verified: 2023-07